Acer Therapeutics Inc (ACER) stock is higher by 0.78% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With ACER Stock Today?
Acer Therapeutics Inc (ACER) stock is trading at $2.58 as of 2:21 PM on Tuesday, Jan 12, a rise of $0.11, or 4.49% from the previous closing price of $2.47. Volume today is more active than usual. So far 1,510,120 shares have traded compared to average volume of 199,376 shares. The stock has traded between $2.44 and $2.74 so far today.
To see the top 5 stocks in the Biotechnology industry click here.
More About Acer Therapeutics Inc
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.
Click Here to get the full Stock Score Report on Acer Therapeutics Inc (ACER) Stock.
